Molecular Monitoring With Circulating Tumor DNA and Nivolumab Maintenance

Clinical trial NCT03311958 · COMPLETED

Trial details

NCT number: NCT03311958
Sponsor: Fox Chase Cancer Center
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2018-05-15
Primary completion: 2024-01-26
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.